Mark S. Levine, Chief Legal Officer at Immunovant, Inc. (IMVT), sold 4,863 shares at $29.64 ($144K) on 2024-07-17, disclosed to the SEC on 2024-07-19.
Open-market sale of $144k IMVT by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.64 | 2,358 | $70K | 48.4% |
| 2 | $29.64 | 2,358 | $70K | 48.4% |
| 3 | $30.55 | 147 | $4K | 3.1% |
| Total | $29.67 avg | 4,863 | $144K | 100% |
| Filing → |
| IMVT | SELL | 2024-10-18 | $165K | — | Filing → |
| IMVT | SELL | 2024-08-23 | $206K | — | Filing → |
| IMVT | SELL | 2024-07-26 | $223K | — | Filing → |